Skip to content

Auph stock forum

Auph stock forum

Mar 31, 2020 · - Data to be shared as a late-breaking oral presentation during the live virtual NKF conference - Aurinia Pharmaceuticals Inc. (AUPH), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that clinical data from its AURORA Phase 3 trial will be highlighted in a late-breaking oral presentation … AUPH / Aurinia Pharmaceuticals Inc - Institutional ... Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has 6 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 140,000 shares. AUPH Aurinia Pharmaceuticals Inc. Stock Quote Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of various diseases in the United States and China.

AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH ... Mar 25, 2020 · Aurinia Pharmaceuticals Inc is estimated to report earnings on 05/12/2020. The upcoming earnings date is derived from an algorithm based on …

AUPH Stock Price, Forecast & News (Aurinia Pharmaceuticals)

AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The AUPH Whisperer (@Aurinia) | Stocktwits The latest messages and market ideas from The AUPH Whisperer (@Aurinia) on Stocktwits. The largest community for investors and traders

Aurinia Pharmaceuticals Inc - AUPH - Stock Price Today - Zacks

NASDAQ:AUPH / Aurinia Pharmaceuticals Inc - Stock Price ... AUPH / Aurinia Pharmaceuticals Inc 6-K - Current Report of Foreign Issuer - AURINIA PHARMACEUTICALS INC. 6-K. 03-19 sec.gov - 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 …

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has 6 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 140,000 shares.

The AUPH Whisperer (@Aurinia) | Stocktwits The latest messages and market ideas from The AUPH Whisperer (@Aurinia) on Stocktwits. The largest community for investors and traders Aurinia Pharmaceuticals Inc. (AUPH) Stocktalk | Seeking Alpha Read the latest StockTalks, investment ideas, and community discussion on Aurinia Pharmaceuticals Inc. (AUPH).

Apex Business WordPress Theme | Designed by Crafthemes